Breaking News
December 12, 2017 - CAR T cell therapy shows long-lasting remissions in non-Hodgkin’s lymphoma patients
December 12, 2017 - Live-cell microscopy reveals internal forces that direct cell migration
December 12, 2017 - GSK Submits US Regulatory Application for Single-Dose Tafenoquine for Plasmodium vivax Malaria
December 12, 2017 - High Blood Urea Nitrogen Levels Tied to T2D Risk
December 12, 2017 - Blood Smear: MedlinePlus Lab Test Information
December 12, 2017 - Atopic eczema—one size does not fit all
December 12, 2017 - Biological Applications of AFM
December 12, 2017 - Study provides new insights into mechanism of tumor survival in glioblastoma
December 12, 2017 - FDA Approves Admelog (insulin lispro) Short-Acting “Follow-On” Insulin Product to Treat Diabetes
December 12, 2017 - Chromosomes Fact Sheet – National Human Genome Research Institute (NHGRI)
December 12, 2017 - Discovery puts the brakes on HIV’s ability to infect
December 12, 2017 - Researchers uncover novel strategy to program immune system for fighting cancer
December 12, 2017 - Study finds under-age marriage for women as marker of multiple vulnerabilities
December 12, 2017 - Scientists discover specific mechanism of Zika virus-associated microcephaly
December 12, 2017 - Creating Your Family Health Tree
December 12, 2017 - Biological Pathways Fact Sheet – National Human Genome Research Institute (NHGRI)
December 12, 2017 - LSUHealthNO breakthrough may pave way for advances in obesity-related diseases
December 12, 2017 - Few people with HIV get prompt care after incarceration
December 11, 2017 - Air pollution exposure before or after conception linked to increased risk of birth defects in children
December 11, 2017 - Abu Dhabi focuses on reducing childhood obesity
December 11, 2017 - Employees with influenza have more lost work time
December 11, 2017 - type 2 diabetes – Genetics Home Reference
December 11, 2017 - Insufficient evidence to guide recommendations on vitamin D in pregnancy
December 11, 2017 - St. Jude gene therapy offers hope for infants with ‘bubble boy’ disease
December 11, 2017 - Soy foods, cruciferous vegetables may reduce breast cancer treatment’s side effects
December 11, 2017 - Nearly 3 in 10 elite footballers at top clubs have undetected lung and airway problems, study finds
December 11, 2017 - Why some workers can’t call it quits
December 11, 2017 - Healthier Diet, Less Salt: The Recipe to Beat High Blood Pressure: MedlinePlus Health News
December 11, 2017 - Research leads to call for lung health screening at top football clubs
December 11, 2017 - Drug improves disease-free, overall survival after hematopoietic stem cell transplants
December 11, 2017 - Researchers generate 3D cell cultures to investigate mechanisms of drug resistance in breast cancer
December 11, 2017 - New, more easily administered therapies offer benefits for bleeding and clotting disorders
December 11, 2017 - Opioids after surgery left her addicted. Is that a medical error?
December 11, 2017 - Scientists develop software that predicts leukemia-specific immune targets
December 11, 2017 - Does Your Pet Have a Weight Problem? Here’s How to Tell: MedlinePlus Health News
December 11, 2017 - Genetic variant prompts cells to store fat, fueling obesity
December 11, 2017 - Canola oil linked to worsening of Alzheimer’s
December 11, 2017 - New Breast Cancer Drug Ribociclib (Kisqali) May Benefit Younger Women, Too
December 11, 2017 - Healthy Living May Ease Some MS Symptoms: MedlinePlus Health News
December 11, 2017 - Researchers develop a molecular taxonomy for hair disorders
December 11, 2017 - Study shows safety, efficacy of cystic fibrosis drug in children between 1 to 2 years of age
December 11, 2017 - Two immunotherapy approaches for multiple myeloma show hope
December 11, 2017 - The Valley Hospital uses novel mobile app to enhance pre-hospital emergency care
December 11, 2017 - ‘I Entered Medical School Through a Hunger Strike’: What We Heard This Week
December 11, 2017 - Research team unlocks secrets of Ebola
December 11, 2017 - Generic versions of Viagra coming this week
December 11, 2017 - New genetic model identified for predicting outcomes in patients with primary myelofibrosis
December 11, 2017 - Research shows that e-cigarettes serve as gateway to traditional smoking
December 11, 2017 - A risk factor for drug-induced skin disease identified
December 11, 2017 - MIT researchers discover new way to make bacteria vulnerable to existing antibiotics
December 11, 2017 - Dengue vaccine issues in the Philippines
December 11, 2017 - Office Workers Don’t Like Being Chained to Their Desks: MedlinePlus Health News
December 11, 2017 - Study reveals how a very low calorie diet can reverse type 2 diabetes
December 11, 2017 - Study highlights potential for reducing greenhouse gas emissions in health care settings
December 11, 2017 - University of Adelaide receives $23.2 million for preterm birth research
December 11, 2017 - Tough Flu Season Ahead: Vaccine May Only Be 10% Effective
December 11, 2017 - Getting Self-Driving Cars on the Road Soon Might Save Lives: MedlinePlus Health News
December 11, 2017 - Enterovirus vaccine prevents virus-induced diabetes in a T1D experimental model
December 11, 2017 - Solar retinopathy or sun damage to the eyes – a case report
December 11, 2017 - Cancer risk with birth control pills emerges again in latest study
December 10, 2017 - Deer Hunters: Put Safety First: MedlinePlus Health News
December 10, 2017 - High blood pressure is redefined as 130, not 140: US guidelines (Update)
December 10, 2017 - Unusual neuroinflammation may underlie cognitive problems in cART-treated HIV patients
December 10, 2017 - Racial differences in parents’ reports of child’s autism symptoms may contribute to delayed diagnosis
December 10, 2017 - Taurine could boost effectiveness of existing multiple sclerosis therapies
December 10, 2017 - The man with a young woman’s heart
December 10, 2017 - Patient bedside remains important component of medical education for students
December 10, 2017 - Nutrition labeling has little impact on sodium consumption
December 10, 2017 - ‘Obesity paradox’ not present among people with new cases of cardiovascular disease
December 10, 2017 - SLU scientists provide promising approach in designing new drugs for DMD
December 10, 2017 - Can PD-1 Inhibitor Help Eradicate HIV?
December 10, 2017 - Checking Prices for Medical Procedures Online? Good Luck: MedlinePlus Health News
December 10, 2017 - Researchers find bacteria tied to esophageal cancer
December 10, 2017 - Boy’s Double Hand Transplant Changed His Brain
December 10, 2017 - Memo to Doctors: Spit Out the Bad News: MedlinePlus Health News
December 10, 2017 - Two years of extended anastrozole therapy proved as effective as five years in clinical trial
December 10, 2017 - Using digital devices before bed may contribute to sleep and nutrition problems in children
December 10, 2017 - Are You Sure That’s What the Doctor Said About Your Leukemia?: MedlinePlus Health News
December 10, 2017 - Low vitamin D levels at birth linked to higher autism risk
December 10, 2017 - Alcohol use in movies influences onset of drinking among 10- to 15-year-olds
Patients with Cancer Face PTSD Risk

Patients with Cancer Face PTSD Risk

image_pdfDownload PDFimage_print

Action Points

  • More than 20% of patients with cancer had symptoms of post-traumatic stress disorder a month after diagnosis, and the symptoms persisted long-term a third of the time.
  • The study findings are consistent with several recent studies showing that many patients with cancer have persistent fear of disease recurrence, even after successful treatment.

More than 20% of patients with cancer had symptoms of post-traumatic stress disorder (PTSD) a month after diagnosis, and the symptoms persisted long-term a third of the time, a prospective study showed.

Overall, 44 of 203 patients met diagnostic criteria for PTSD (including subsyndromal PTSD) 6 months after diagnosis of cancer. At 4 years, 15 of the 45 patients had persistent or worsening symptoms of PTSD, as reported online in Cancer.

“Our data underscore the risk of developing persistent PTSD even years after cancer diagnosis and treatment,” said Lei Hum Wee, PhD, of the National University of Malaysia in Kuala Lumpur, and colleagues. “Approximately one-third of patients with cancer who are initially diagnosed with full or subsyndromal PTSD at 6 months went on to develop chronic or full PTSD at 4 years follow-up.”

“This highlights a need to monitor PTSD among long-term cancer survivors, especially because many of the symptoms of PTSD, such as avoidance and cognitive difficulties (as well as psychological distress), are enduring, which may potentially impact adherence to treatment,” they noted.

The findings are consistent with several recent studies showing that many patients with cancer have persistent fear of disease recurrence, even after successful treatment. For example, a study reported earlier this year at the American Society of Clinical Oncology (ASCO) meeting showed that more than half of cancer survivors had “emotional distress that is insufficiently addressed by survivor care planning and supportive services.”

Also at the 2017 ASCO meeting, investigators from Australia reported that cancer survivors who underwent a form of cognitive behavioral therapy had significant improvement in anxiety and distress associated with fear of cancer recurrence.

Previous studies of PTSD in patients with cancer have shown incidences ranging from 0% to 6% with use of structured diagnostic interviews, Wee’s group noted. The literature included six studies with at least 100 patients, most of whom were women with breast or gynecologic cancers. The only study with a longitudinal design showed that more than half the patients had at least one symptom of PTSD a year after cancer diagnosis.

“To the best of our knowledge, there are no studies examining PTSD in patients with cancer that have used gold-standard clinical interviews and followed a cohort for a period as long as 4 years,” the authors noted.

The study involved 469 consecutive patients who had cancer diagnoses within the previous month. All patients were evaluated by the Hospital Anxiety and Depression Scale (HADS). Patients with elevated HADS scores at 6 months were evaluated by the Structured Clinical Interview for DSM-IV Axis I disorders (SCID) module for PTSD, and all patients had SCID evaluations at 4 years.

A PTSD diagnosis required that a patient meet criteria specified by DSM-IV: traumatic exposure (cancer diagnosis) and response associated with at least one recurring symptom, three avoidance/numbing symptoms, and two arousal symptoms, all persisting for more than a month and resulting in significant distress or functional impairment.

Subsyndromal PTSD was defined as traumatic exposure and response leading to distress or functional impairment persisting more than a month, associated with the presence of at least six symptoms from three of four categories (recurring, avoidance/numbing, hyperarousal, and duration).

At the 6-month follow-up, 203 of 222 patients with elevated HADS scores completed the SCID. During follow-up, 210 of the 469 patients died, and two others were lost to follow-up, leaving 245 patients for the 4-year evaluation.

The data showed that 27 patients met criteria for a PTSD diagnosis and 17 met criteria for subsyndromal PTSD, resulting in a total PTSD incidence of 21.7%. At the 4-year follow-up, 10 of the 245 (4.1%) evaluable patients had overt PTSD and five (2%) had subsyndromal PTSD, resulting in a total prevalence of 6.1%.

Six of 27 (22.2%) patients with overt PTSD at 6 months still met diagnostic criteria for PTSD at 4 years, two (7.4%) had subsyndromal PTSD, three (11.1%) no longer met diagnostic criteria for PTSD, one patient was lost to follow-up (3.7%), and 15 (55.6%) had died. Of the 17 patients with subsyndromal PTSD at 6 months, three (17.6%) had overt PTSD, four (23.5%) no longer met PTSD diagnostic criteria, and 10 (58.8%) had died.

Overall, 15 of 44 (34.1%) patients who had PTSD diagnoses at 6 months (including subsyndromal PTSD) had overt PTSD at 4 years.

An analysis of potential predictors of PTSD showed that patients with breast cancer were significantly less likely to develop PTSD by the 6-month assessment (OR 0.272, 95% CI 0.089-0.834).

Study limitations included the fact that the patient population was from one academic medical center, and the small number of patients diagnosed with PTSD using SCID.

The study was funded by the National University of Malaysia (University Kebangsaan Malaysia).

Wee and co-authors disclosed no relevant disclosures with industry.

  • Reviewed by
    Robert Jasmer, MD Associate Clinical Professor of Medicine, University of California, San Francisco and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2017-11-20T00:01:00-0500

Tagged with:

About author

Related Articles